Finance

Lists
GDTC:NASDAQ
CytoMed Therapeutics Ltd
$0.84
-1.73%
(-0.015) 1D
Oct 15, 10:18:04 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GDTC...
Open
$0.81
High
$0.88
Low
$0.73
Mkt. cap
10.08M
Avg. vol.
18.57K
Volume
1.43K
52-wk high
$3.68
52-wk low
$0.68
EPS
-$0.23
Beta
0.06
Shares outstanding
11.83M
No. of employees
42
Open
$0.81
High
$0.88
Low
$0.73
Mkt. cap
10.08M
Avg. vol.
18.57K
Volume
1.43K
52-wk high
$3.68
52-wk low
$0.68
EPS
-$0.23
Beta
0.06
Shares outstanding
11.83M
No. of employees
42
News stories
From web sources and news partners
About CytoMed Therapeutics Ltd
CEO-
Employees42
Founded2018
Headquarters-
SectorBiotechnology
Websitew2.cytomed.sg
Analyst ratings
Based on 1 analyst giving stock ratings to GDTC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GDTC in the last 3 months
Highest
Current $0.84
$4.16 (+392.31%)
Average
$4.16 (+392.31%)
Lowest
$4.16 (+392.31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Siddharth Rajeev
Fundamental Research
Buy
Initiated
$4.16
+392.3%
09/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in SGD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
205.08K
205.08K
189.44K
189.44K
Cost of goods sold
31.99K
31.99K
23.66K
23.66K
Cost of revenue
31.99K
31.99K
23.66K
23.66K
Research and development expenses
527.51K
527.51K
547.78K
547.78K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
294.91K
294.91K
194.40K
194.40K
Operating expense
1.27M
1.27M
1.07M
1.07M
Total operating expenses
1.30M
1.30M
1.09M
1.09M
Operating income
-1.10M
-1.10M
-901.91K
-901.91K
Other non operating income
31.60K
31.60K
2.18K
2.18K
EBT including unusual items
-875.25K
-875.25K
-897.07K
-897.07K
EBT excluding unusual items
-1.02M
-1.02M
-896.95K
-896.95K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
370.51K
370.51K
268.90K
268.90K
Net income
-868.35K
-868.35K
-885.23K
-885.23K
Net profit margin
-423.42%
-423.42%
-467.29%
-467.29%
Earnings per share
-
-
-
-
Interest and investment income
19.05K
19.05K
4.78K
4.78K
Interest expense
-5.30K
-5.30K
-5.07K
-5.07K
Net interest expenses
13.75K
13.75K
-295.00
-295.00
Depreciation and amortization charges
58.31K
58.31K
63.91K
63.91K
EBITDA
-995.61K
-995.61K
-783.53K
-783.53K
Gain or loss from assets sale
-122.00
-122.00
125.00
125.00
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps